InVitae (NVTA) Misses Q2 EPS by 1c

InVitae (NYSE: NVTA) reported Q2 EPS of ($0.77), $0.01 worse than the analyst estimate of ($0.76). Revenue for the quarter came in at $5.6 million versus the consensus estimate of $5.81 million.

For earnings history and earnings-related data on InVitae (NVTA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c